GPNT

9061601, rat brain, Fusiform

• Codice UNSPSC: 41106514
• Origine biologica: rat brain
• Modalità di accrescimento: Adherent
• Cariotipo: Not specified
• Morfologia: Fusiform
• Prodotti: GPNT cells express tight junction proteins
• Recettori: P-glycoprotein, PECAM-1, ICAM-1, VCAM-1 Glut-1, transferrin receptor, MHC class I

Proprietà

• Nome del prodotto: GPNT, from rat brain, 09061601
• Origine biologica: rat brain
• Modalità di accrescimento: Adherent
• Cariotipo: Not specified
• Morfologia: Fusiform
• Prodotti: GPNT cells express tight junction proteins
• Recettori: P-glycoprotein, PECAM-1, ICAM-1, VCAM-1 Glut-1, transferrin receptor, MHC class I
• tecniche: cell culture | mammalian: suitable
• Condizioni di spedizione: dry ice

Descrizione

Origine della linea cellulare

An immortalised Lewis rat brain vascular endothelial cell line

Descrizione della linea cellulare

GPNT was derived from the immortalised rat brain endothelial cell line GP8 by lipofectin-mediated transfection with a vector containing the puromycin resistance gene. GPNT exhibits a non-transformed phenotype.

Profilo DNA

Not specified

Terreno di coltura

Hams F10 + 10% Heat-inactivated FCS + 2 mM Glutamine + 2 ng/ml basic fibroblast growth factor + 80 μg/ml heparin. All plasticware is pre-coated for several hours with collagen (Type I from calf skin) at 10μg/cm2 from a 0.01% solution in acetic acid. After removal the coated plasticware is exposed to a mMonia vapour for 5 min. Plasticware must be rinsed thoroughly with PBS prior to use.

Mantenimento delle subcolture

Split sub-confluent cultures (70-80%) 1:4 to 1:10 , i.e., seeding at 3 x 10,000 cells/cm² using 0.05% trypsin or trypsin/EDTA; 5% CO₂; 37 °C. Population doubling approx 10hrs.

Altre note

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.

Esclusione di responsabilità

This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form.